Ezekiel J. Emanuel and Abe Baker-Butler predict that by 2030, autonomous AI will outperform both doctors working alone and those supported by AI in five fundamental cognitive medical tasks.
The FDA's approval of Rasonque, a novel drug for pancreatic cancer, was a major milestone for researchers aiming to improve treatment outcomes. However, despite this regulatory success, many patients are experiencing difficulties in obtaining timely access to the medication, raising concerns about distribution and availability.
In this episode of STAT Health Tech, we explore how Stryker is integrating Apple's Vision Pro virtual reality headset into surgical procedures, creating an innovative 'surgical cockpit.' We also cover the use of chatbots to combat loneliness and other developments in health technology.
Several major health organizations are implementing AI-driven chatbots to access and summarize patient records efficiently. These tools help clinicians save valuable time and improve the accuracy of diagnoses.
Financial incentives play a significant role as health care accounts for nearly 20% of the American economy, attracting every major AI company to invest heavily in this sector.
Paul Martin Jensen and Avi Tuschman suggest that combating medical misinformation could be more effective if people were better equipped to recognize when they are being manipulated. Making this process easier could disrupt the current health misinformation business model.
Medicare's payment policy for hospitals using newly-approved AI devices may unintentionally encourage excessive use, according to researchers.
Commure is on a bold mission to streamline healthcare administration using AI technology. This inside perspective explores the complex challenges the startup faces as it works to automate the intricate and often chaotic business side of healthcare.
Former surgeon Frances Mei Hardin argues that AI itself is not to blame; rather, it acts as a reflection of the ongoing reduction in physician judgment and autonomy.
Federal health officials have organized private meetings with technology companies, researchers, and lobbyists to encourage greater adoption of clinical artificial intelligence in healthcare settings.
